DUPONT CAPITAL MANAGEMENT CORP - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DUPONT CAPITAL MANAGEMENT CORP ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q2 2015$334,000
-5.4%
28,410
+16.6%
0.01%0.0%
Q1 2015$353,000
-9.9%
24,370
+6.0%
0.01%0.0%
Q4 2014$392,000
+8.9%
22,980
-20.6%
0.01%
+16.7%
Q3 2014$360,000
-36.7%
28,930
-25.5%
0.01%
-33.3%
Q2 2014$569,00038,8100.01%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Eventide Asset Management 579,800$7,224,0001.01%
VHCP Management, LLC 71,000$884,0000.40%
Healthcare Value Capital, LLC 16,464$205,0000.20%
CARL DOMINO INC 22,196$277,0000.15%
TFS CAPITAL LLC 120,112$1,497,0000.13%
Private Capital Advisors, Inc. 31,064$387,0000.12%
Artal Group S.A. 170,000$2,118,0000.08%
TimesSquare Capital Management, LLC 801,225$9,983,0000.06%
Baker Brothers Advisors 338,671$4,220,0000.05%
STONERIDGE INVESTMENT PARTNERS LLC 19,399$242,0000.04%
View complete list of STEMLINE THERAPEUTICS INC shareholders